In fact, research shows that people with this gene mutation still process this nutrient, although the amount is about 16% lower
We should also look at what is being done to raise awareness and ensure better diagnosis and treatment for people with Pernicious Anaemia and B12 deficiency from other causes
Decision Framework: Which to Choose The choice between AOD-9604 and tesamorelin depends entirely on whether the research wants to engage the GH axis or isolate specific GH effects: Choose AOD-9604 if: Research focuses specifically on lipolytic activity without GH receptor engagement Studies want to avoid IGF-1 elevation and broader GH effects The receptor-independent mechanism is part of the research question Fat metabolism research without confounding GH signaling effects is the goal Choose tesamorelin if: Research focuses on GHRH receptor pharmacology or pituitary GH axis Studies want full GH axis activation including IGF-1 elevation The natural pulsatile GH release pattern is biologically relevant DPP-4-resistant GHRH analog mechanism is the research focus Choose neither (or both) if: Research focuses on different aspects of GH biology Comparative research between upstream and downstream GH peptides is the goal Other GH-related compounds (sermorelin, CJC-1295, ipamorelin) are more relevant see Sermorelin, CJC-1295, and Ipamorelin Research Overview Quality Considerations Both peptides share the same quality framework: Manufactured via Solid-Phase Peptide Synthesis with synthetic amino acids Specific N-terminal modifications incorporated as synthesis steps No animal-derived materials Independent third-party testing by Janoshik Analytical 99% HPLC purity per peptide Mass spectrometry identity confirmation (particularly important for confirming the modifications) For complete quality framework coverage, see How to Verify Peptide Quality and How to Read a Janoshik COA
Murdoch Childrens Research Institute (England) The Murdoch Childrens Research Institute is running a Phase III trial repurposing Bacillus Calmette-Guerin -- a vaccine developed nearly a century ago to prevent tuberculosis infections -- to prevent Covid-19
The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
